Medical/Pharmaceuticals
Macrogen obtained export approval for COVID-19 test kit 'AxenTM COVID-19 RT'
SEOUL, South Korea, May 21, 2020 /PRNewswire/ -- The Korean biotech company
Macrogen
Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology
MELBOURNE, Austrilia and SAN FRANCISCO, May 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has presented data on ATH434 (formerly PBT434) for the treatment of Multiple System Atrophy at the American Academy of Neurology (AAN) virtual meeting....
China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction
BEIJING, May 20, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today declared that Xinjiang Deyuan Bioengineering Co., Ltd. ("Xinjiang Deyuan"), China Biolog...
China Biologic Reports Financial Results for the First Quarter of 2020
BEIJING, May 20, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the first quarter of 2020. First Quarter ...
Macrogen Approved for Export of its COVID-19 Test Kit
SEOUL, South Korea, May 20, 2020 /PRNewswire/ -- The Korean biotech company
Macrogen
Marketing Authorization Application for Luye Pharma's Rivastigmine Multi-Day Transdermal Patch Product Rivalif® under Review at EU Competent Authorities
MISBACH, Germany, May 20, 2020 /PRNewswire/ -- Luye Pharma Group announced today that the Marketing Authorization Application (MAA) within the European territory for its Rivastigmine Multi-Day Transdermal Patch (Brand Name: Rivalif® , Product Code: LY30410), an innovative drug delivery system, is ...
Retailers Rely on DERMALOG's Fever Screening
The Corona pandemic poses significant challenges for retail stores and shopping centers. Businesses must implement numerous health protection measures without compromising customer experience too much. This is why German Scandinavian Park mall has opted for DERMALOG's non-contact fever detection....
INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models
- Publication in Nature Communications demonstrates generation of robust neutralizing antibodies and T cell responses against SARS-CoV-2 - Preliminary safety and immune responses data from Phase 1 clinical trial expected in June - Multiple animal challenge study data expected in coming weeks ...
COUCH Health Demands the Clinical Research Industry Improves Participant Diversity
As advocates of diverse and inclusive clinical trials, patient engagement agency COUCH Health is calling on the industry take action to make clinical research more inclusive and representative of all populations. Demand Diversity has launched with the aim to raise awareness of the lack of diversi...
I-Mab Expands Global Presence with New Hong Kong Office
SHANGHAI and ROCKVILLE, Md., May 20, 2020 /PRNewswire/ -- I-Mab (NASDAQ:IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly ...
It's time to talk: Relationships Australia NSW launches free telephone hotline
SYDNEY, May 20, 2020 /PRNewswire/ -- Relationships Australia NSW has launched
Time 2 Talk, a brand-new telephone hotline that provides support and advice to
help Australians navigate the complexities of day-to-day living amid COVID-19.
DKSH partners with International SOS to safeguard staff and supply chain operations during COVID-19
BANGKOK, May 20, 2020 /PRNewswire/ -- DKSH, Asia's leading Market Expansion
Services provider for companies seeking to grow their business inAsia and
beyond, has entered into a partnership with International SOS, to run DKSH's
Total Quarantine Solution in several markets acrossAsia.
VSMS ECG Patch receives US FDA 'Emergency Use Authorisation' for patients being treated for COVID-19
* Patch now authorised in the USA for emergency use for patients undergoing treatment for COVID-19 * Patch entitled for reimbursement under US CPT code scheme – adds to GMV's growing revenue profile * Large addressable market for G Medical - ~1.5m confirmed cases of COVID-19 recorded in the...
Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen
* As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficacy...
Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification
SONGDO, South Korea, May 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced it has attained ISO22301 certification for additional business operations, demonstrating its unsurpassed commitment to ensuring client satisfaction and operational excellence through its world-class business...
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
AUSTIN, Texas, May 19, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers a...
Glemser Technologies and Arria NLG announce strategic partnership
Together they will accelerate pharma clients' ability to bring life-saving drugs to market through automation of medical and regulatory report writing NEW YORK, May 20, 2020 /PRNewswire/ -- Arria NLG, a leading provider of Natural Language Generation (NLG) technology, today announced a collaborat...
Covis Pharma B.V. Initiates Phase 3 Clinical Trial of Alvesco (Ciclesonide) Inhaler for the Treatment of COVID-19
U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) filing to study the use of Alvesco in COVID-19 Study will evaluate the Safety and Efficacy of Alvesco in the Treatment of Non-hospitalized COVID-19 Patients Aged 12 and Above LUXEMBOURG and ZUG, Swi...
TauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia
Minimum dose of hydromethylthionine could slow clinical decline and brain atrophy in behavioural variant Fronto-Temporal Dementia as well as Alzheimer's Disease ABERDEEN, Scotland and SINGAPORE, May 19, 2020 /PRNewswire/ -- In a paper published online in theJournal of Alzheimer's Disease ( https...
QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to Support Gene Therapy and Protein Drug Development
NEWARK, Delaware, May 19, 2020 /PRNewswire/ -- QPS, a global contract research organization (CRO) that provides discovery, preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics. QPS announces an expanded and up...
Week's Top Stories
Most Reposted
Mastercard goes OTP-free in APAC for faster, safer online transactions
[Picked up by 326 media titles]
2024-11-06 09:00Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 309 media titles]
2024-11-12 09:00Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 284 media titles]
2024-11-12 11:00